ArticleMolecular cancer therapeutics2016

Mutant BRAF Upregulates MCL-1 to Confer Apoptosis Resistance that Is Reversed by MCL-1 Antagonism and Cobimetinib in Colorectal Cancer.

Hisato Kawakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.